title: Transcutaneous immunization in mice: induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors.
abstract: Previous reports have shown that transcutaneous immunization (TCI) with proteins or peptides in combination with adjuvants efficiently induces specific cellular and humoral immune responses. However, depending on the kind of skin pretreatment, induction of cellular immune responses was restricted to generation of either specific cytotoxic T lymphocytes (CTLs) or T-helper (Th) cells. In this study, we induced antigen-specific CTL responses together with the appropriate Th responses by TCI of C57BL/6 mice. We applied ovalbumin protein or an ovalbumin-derived fusion peptide containing a CTL and Th epitope together with a combination of cholera toxin (CT) and CpG oligodeoxynucleotide (CpG) onto cold wax-depilated and hydrated bare skin. TCI with the ovalbumin fusion peptide induced more robust CTL and Th responses than that with ovalbumin protein. The fusion peptide in combination with the nontoxic CT derivative CTA1-D2D1 and CpG induced an antigen-specific CTL response, albeit less efficiently than in combination with complete CT. Further, we compared the potency of HPV-16 E7 oncoprotein-derived peptides containing single (CTL) or multiple (CTL + Th + B cell) epitopes to induce effective CTL responses. Strong E7-specific CTL responses were detected only after TCI with the E7 multiepitope peptide. This peptide was also shown to protect mice against tumor growth after challenge with HPV-16 E7-positive tumor cells. TCI with E7 protein and CT/CpG led to formation of an E7-specific humoral immune response.
authors.affiliation: Deutsches Krebsforschungszentrum, Heidelberg, Germany. k.dell@dkfz.de
authors.forename: Kerstin
authors.initials: K
authors.lastname: Dell
authors.forename: Robert
authors.initials: R
authors.lastname: Koesters
authors.forename: Lutz
authors.initials: L
authors.lastname: Gissmann
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D000917:Antibody Formation; D000939:Epitopes; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D007114:Immunization / Q000662:veterinary; D016399:Lymphoma, T-Cell / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D010047:Ovalbumin / Q000276:immunology; D030361:Papillomavirus Infections / Q000150:complications* / Q000276:immunology*; D010455:Peptides; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*; D013945:Thymoma / Q000276:immunology; D014162:Transfection
chemical_list: D000939:Epitopes; D010455:Peptides; D010047:Ovalbumin